1. Home
  2. MTX vs SLNO Comparison

MTX vs SLNO Comparison

Compare MTX & SLNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Minerals Technologies Inc.

MTX

Minerals Technologies Inc.

HOLD

Current Price

$67.01

Market Cap

2.1B

Sector

Industrials

ML Signal

HOLD

Logo Soleno Therapeutics Inc.

SLNO

Soleno Therapeutics Inc.

HOLD

Current Price

$33.29

Market Cap

2.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MTX
SLNO
Founded
1968
1999
Country
United States
United States
Employees
3782
N/A
Industry
Major Chemicals
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
2.3B
IPO Year
2004
2014

Fundamental Metrics

Financial Performance
Metric
MTX
SLNO
Price
$67.01
$33.29
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
11
Target Price
$81.33
$105.27
AVG Volume (30 Days)
161.5K
1.4M
Earning Date
04-23-2026
05-06-2026
Dividend Yield
0.71%
N/A
EPS Growth
N/A
108.90
EPS
N/A
0.39
Revenue
$2,072,600,000.00
$1,450,788.00
Revenue This Year
$5.66
$150.65
Revenue Next Year
$4.47
$56.10
P/E Ratio
N/A
$85.97
Revenue Growth
N/A
138.82
52 Week Low
$49.54
$32.15
52 Week High
$75.30
$89.12

Technical Indicators

Market Signals
Indicator
MTX
SLNO
Relative Strength Index (RSI) 40.85 34.35
Support Level $64.90 $32.63
Resistance Level $69.76 $41.48
Average True Range (ATR) 2.14 1.99
MACD -0.31 -0.49
Stochastic Oscillator 26.44 14.21

Price Performance

Historical Comparison
MTX
SLNO

About MTX Minerals Technologies Inc.

Minerals Technologies Inc mines, produces, and sells mineral-based products. The firm organizes itself into two segments: The Consumer & Specialties segment that derives maximum revenue, serves consumer end markets directly with mineral-to-market finished products and also provides specialty mineral-based solutions and technologies that are an essential component of its customers' finished products; and The Engineered Solutions segment serves industrial end markets with engineered systems, mineral blends, and technologies that are designed to improve its customers' manufacturing processes and projects. The majority of revenue comes from the United States, while it also has its presence in Canada/Latin America, Europe/Africa, and Asia.

About SLNO Soleno Therapeutics Inc.

Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.

Share on Social Networks: